Search hospitals > Pennsylvania > Sayre

Guthrie Medical Group PC-Robert Packer Hospital

Claim this profile
Sayre, Pennsylvania 18840
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
137 reported clinical trials
6 medical researchers
Photo of Guthrie Medical Group PC-Robert Packer Hospital in SayrePhoto of Guthrie Medical Group PC-Robert Packer Hospital in Sayre

Summary

Guthrie Medical Group PC-Robert Packer Hospital is a medical facility located in Sayre, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Guthrie Medical Group PC-Robert Packer Hospital is involved with conducting 137 clinical trials across 242 conditions. There are 6 research doctors associated with this hospital, such as Joyson Poulose, Philip A. Lowry, Thomas J. Gergel, and Vineela Kasireddy.

Area of expertise

1Cancer
Global Leader
Guthrie Medical Group PC-Robert Packer Hospital has run 47 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
HER2 positive
2Breast Cancer
Global Leader
Guthrie Medical Group PC-Robert Packer Hospital has run 31 trials for Breast Cancer. Some of their research focus areas include:
ER positive
Stage IV
HER2 negative

Top PIs

Clinical Trials running at Guthrie Medical Group PC-Robert Packer Hospital

Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Small Cell Lung Cancer
Skin Cancer
Pancreatic Cancer
Cutaneous Melanoma
Solid Tumors
Multiple Myeloma
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Guthrie Medical Group PC-Robert Packer Hospital?
Guthrie Medical Group PC-Robert Packer Hospital is a medical facility located in Sayre, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Guthrie Medical Group PC-Robert Packer Hospital is involved with conducting 137 clinical trials across 242 conditions. There are 6 research doctors associated with this hospital, such as Joyson Poulose, Philip A. Lowry, Thomas J. Gergel, and Vineela Kasireddy.